BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Skin cancer AND BCL7A, BCL7, 605, ENSG00000110987 AND Treatment
22 results:

  • 1. Prognostic nomograms for predicting long-term overall survival in spindle cell melanoma: a population-based study.
    Lau WC; Huang L; Zheng X; Ming WK; Leong NC; Tak Wong Y; Yin Z; Yu H; Lyu J; Deng L
    Front Endocrinol (Lausanne); 2024; 15():1260966. PubMed ID: 38572477
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. The Predictive Value of FDG PET/CT for Determining Progression-Free Survival in Advanced Stage III-IV BRAF -Mutated Melanoma Patients Treated With Targeted Therapy-What Can Be Learned From Progression?
    van der Hiel B; Aalbersberg EA; van den Eertwegh AJM; de Wit-van der Veen LJ; Stokkel MPM; Lopez-Yurda M; Boellaard R; Kapiteijn EW; Hospers GAP; Aarts MJB; de Vos FYFL; Boers-Sonderen MJ; van der Veldt AAM; de Groot JWB; Haanen JBAG
    Clin Nucl Med; 2024 Feb; 49(2):138-145. PubMed ID: 38113329
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Intensified Adjuvant treatment for High-Risk Resected Cutaneous Angiosarcoma of the Head and Neck.
    El Shatanofy M; Thakkar P; Patel V; Joshi A; Goodman J; Siegel R; Haroun F; Ojong-Ntui M; Goyal S; Bauman J; Rao YJ
    Otolaryngol Head Neck Surg; 2023 Nov; 169(5):1225-1233. PubMed ID: 37464928
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Clinical characteristics of gastrointestinal immune-related adverse events of immune checkpoint inhibitors and their association with survival.
    Yamada K; Sawada T; Nakamura M; Yamamura T; Maeda K; Ishikawa E; Iida T; Mizutani Y; Kakushima N; Ishikawa T; Furukawa K; Ohno E; Honda T; Kawashima H; Ishigami M; Furune S; Hase T; Yokota K; Maeda O; Hashimoto N; Akiyama M; Ando Y; Fujishiro M
    World J Gastroenterol; 2021 Nov; 27(41):7190-7206. PubMed ID: 34887637
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. cancer immune control dynamics: a clinical data driven model of systemic immunity in patients with metastatic melanoma.
    Frisch HP; Sprau A; McElroy VF; Turner JD; Becher LRE; Nevala WK; Leontovich AA; Markovic SN
    BMC Bioinformatics; 2021 Apr; 22(1):197. PubMed ID: 33863290
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. International prognostic scoring system for mastocytosis (IPSM): a retrospective cohort study.
    Sperr WR; Kundi M; Alvarez-Twose I; van Anrooij B; Oude Elberink JNG; Gorska A; Niedoszytko M; Gleixner KV; Hadzijusufovic E; Zanotti R; Bonadonna P; Bonifacio M; Perkins C; Illerhaus A; Elena C; Merante S; Shoumariyeh K; von Bubnoff N; Parente R; Jawhar M; Belloni Fortina A; Caroppo F; Brockow K; Zink A; Fuchs D; Kilbertus AJ; Yavuz AS; Doubek M; Hägglund H; Panse J; Sabato V; Bretterklieber A; Niederwieser D; Breynaert C; Hartmann K; Triggiani M; Nedoszytko B; Reiter A; Orfao A; Hermine O; Gotlib J; Arock M; Kluin-Nelemans HC; Valent P
    Lancet Haematol; 2019 Dec; 6(12):e638-e649. PubMed ID: 31676322
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. National Analysis of Patients With External Ear Melanoma in the United States.
    Oliver JD; Boczar D; Sisti A; Huayllani MT; Restrepo DJ; Spaulding AC; Gabriel E; Bagaria S; Rinker BD; Forte AJ
    J Craniofac Surg; 2019; 30(8):e787-e790. PubMed ID: 31369498
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Risankizumab compared with adalimumab in patients with moderate-to-severe plaque psoriasis (IMMvent): a randomised, double-blind, active-comparator-controlled phase 3 trial.
    Reich K; Gooderham M; Thaçi D; Crowley JJ; Ryan C; Krueger JG; Tsai TF; Flack M; Gu Y; Williams DA; Thompson EHZ; Paul C
    Lancet; 2019 Aug; 394(10198):576-586. PubMed ID: 31280967
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. A peer review process as part of the implementation of clinical pathways in radiation oncology: Does it improve compliance?
    Gebhardt BJ; Heron DE; Beriwal S
    Pract Radiat Oncol; 2017; 7(5):332-338. PubMed ID: 28284760
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Incidence of Programmed Cell Death 1 Inhibitor-Related Pneumonitis in Patients With Advanced cancer: A Systematic Review and Meta-analysis.
    Nishino M; Giobbie-Hurder A; Hatabu H; Ramaiya NH; Hodi FS
    JAMA Oncol; 2016 Dec; 2(12):1607-1616. PubMed ID: 27540850
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Comparison of Mammographic Changes Across Three Different Fractionation Schedules for Early-Stage Breast cancer.
    Tian S; Paster LF; Kim S; Kirstein L; Haffty BG; Ferro A; Amorosa J; Goyal S
    Int J Radiat Oncol Biol Phys; 2016 Jun; 95(2):597-604. PubMed ID: 27034177
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Mutated BRAF Emerges as a Major Effector of Recurrence in a Murine Melanoma Model After treatment With Immunomodulatory Agents.
    Zaidi S; Blanchard M; Shim K; Ilett E; Rajani K; Parrish C; Boisgerault N; Kottke T; Thompson J; Celis E; Pulido J; Selby P; Pandha H; Melcher A; Harrington K; Vile R
    Mol Ther; 2015 May; 23(5):845-856. PubMed ID: 25544599
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Prevalence of post-mastectomy pain syndrome and associated risk factors: a cross-sectional cohort study.
    Couceiro TC; Valença MM; Raposo MC; Orange FA; Amorim MM
    Pain Manag Nurs; 2014 Dec; 15(4):731-7. PubMed ID: 24144570
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Epigenetic profiling of cutaneous T-cell lymphoma: promoter hypermethylation of multiple tumor suppressor genes including bcl7a, PTPRG, and p73.
    van Doorn R; Zoutman WH; Dijkman R; de Menezes RX; Commandeur S; Mulder AA; van der Velden PA; Vermeer MH; Willemze R; Yan PS; Huang TH; Tensen CP
    J Clin Oncol; 2005 Jun; 23(17):3886-96. PubMed ID: 15897551
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Role of cross-talk between IFN-alpha-induced monocyte-derived dendritic cells and NK cells in priming CD8+ T cell responses against human tumor antigens.
    Tosi D; Valenti R; Cova A; Sovena G; Huber V; Pilla L; Arienti F; Belardelli F; Parmiani G; Rivoltini L
    J Immunol; 2004 May; 172(9):5363-70. PubMed ID: 15100276
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Histologic multifocality is predictive of skin recurrences after conserving treatment of stage I and II breast cancers.
    Marret H; Perrotin F; Bougnoux P; Giraudeau B; Hubert B; Fetissof F; Le Floch O; Lansac J; Body G
    Breast Cancer Res Treat; 2001 Jul; 68(1):1-8. PubMed ID: 11678304
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Perineural spread of basal cell carcinomas treated with Mohs micrographic surgery.
    Ratner D; Lowe L; Johnson TM; Fader DJ
    Cancer; 2000 Apr; 88(7):1605-13. PubMed ID: 10738219
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Risk factors, treatment, and outcome of central nervous system recurrence in adults with intermediate-grade and immunoblastic lymphoma.
    van Besien K; Ha CS; Murphy S; McLaughlin P; Rodriguez A; Amin K; Forman A; Romaguera J; Hagemeister F; Younes A; Bachier C; Sarris A; Sobocinski KS; Cox JD; Cabanillas F
    Blood; 1998 Feb; 91(4):1178-84. PubMed ID: 9454747
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Radiation-induced skin cancer and radiodermatitis of the head and neck.
    van Vloten WA; Hermans J; van Daal WA
    Cancer; 1987 Feb; 59(3):411-4. PubMed ID: 3791154
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. [Dye concentration measurements for the determination of leakage during and following normothermic cytostatic perfusion in the treatment of tumors of the extremities].
    Krauss J; Lange U; Pauer HD; Krauss I
    Z Exp Chir Transplant Kunstliche Organe; 1984; 17(5):269-74. PubMed ID: 6095550
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 2.